CVRx, Inc. Files 2024 10-K with Financials
Ticker: CVRX · Form: 10-K · Filed: Feb 18, 2025 · CIK: 1235912
| Field | Detail |
|---|---|
| Company | Cvrx, Inc. (CVRX) |
| Form Type | 10-K |
| Filed Date | Feb 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, medical-devices
TL;DR
CVRx 2024 10-K is in! Full financials for the year ending Dec 31, 2024, are now public.
AI Summary
CVRx, Inc. filed its 2024 10-K on February 18, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, based in Minneapolis, MN, operates in the surgical and medical instruments sector. Key financial data points such as common stock, retained earnings, additional paid-in capital, and accumulated other comprehensive income were reported for the fiscal years 2022, 2023, and 2024.
Why It Matters
This filing provides investors and analysts with the official year-end financial picture of CVRx, Inc., crucial for understanding the company's financial health and performance trends.
Risk Assessment
Risk Level: medium — As a medical device company, CVRx faces inherent risks related to product development, regulatory approvals, market adoption, and competition, which are detailed in their 10-K filings.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2023-12-31 — Previous Fiscal Year End (Comparative financial data)
- 2022-12-31 — Prior Fiscal Year End (Long-term financial trend analysis)
Key Players & Entities
- CVRx, Inc. (company) — Filer of the 10-K
- December 31, 2024 (date) — Fiscal year end
- February 18, 2025 (date) — Filing date
- Minneapolis, MN (location) — Company headquarters
- 3841 (industry_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
FAQ
What were CVRx, Inc.'s total revenues for the fiscal year ending December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024.
What is CVRx, Inc.'s primary business activity?
CVRx, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, SIC code 3841.
When was the 10-K filing for CVRx, Inc. submitted to the SEC?
The 10-K filing was submitted on February 18, 2025.
What are the key financial statement components reported for CVRx, Inc. in this filing?
The filing mentions reporting for Common Stock, Retained Earnings, Additional Paid-In Capital, and Accumulated Other Comprehensive Income for fiscal years 2022, 2023, and 2024.
Where is CVRx, Inc. headquartered?
CVRx, Inc. is headquartered in Minneapolis, MN.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 18, 2025 regarding CVRx, Inc. (CVRX).